Human Pathology
Volume 41, Issue 5 , Pages 745-750 , May 2010

IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology

Received 3 March 2009 ,Revised 27 April 2009 ,Accepted 28 April 2009.

References 

  1. Roberts F, Harper CM, Downie I, et al. Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. Am J Clin Pathol. 2001;116:253–262
  2. Hanley KZ, Facik MS, Bourne PA, et al. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions. Cancer. 2008;114:49–56
  3. Burd CG, Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science. 1994;29:615–621
  4. Kiledjian M, Wang X, Liebhaber SA. Identification of KH domain proteins in the alpha-globin mRNP stability complex. EMBO J. 1995;14:4357–4364
  5. Mueller-Pillasch F, Lacher U, Wallrapp C, et al. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene. 1997;14:2729–2733
  6. Nielsen J, Christiansen J, Lykke-Andersen J, et al. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol. 1999;19:1262–1270
  7. Yantiss RK, Woda BA, Fanger GR, et al. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol. 2005;29:188–195
  8. Istvanic S, Fanger GR, Fraire AE, et al. Spectrum of KOC (K homology domain containing protein overexpressed in cancer) immunostaining among carcinomas of different sites. Mod Pathol. 2005;18:298A–299A
  9. Mueller F, Bommer M, Lacher U, et al. KOC is a novel molecular indicator of malignancy. Br J Cancer. 2003;88:699–701
  10. Ikeda K, Tate G, Suzuki T, et al. Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: an immunohistochemical analysis and review of the literature. Gynecol Oncol. 2008;108:598–602
  11. Ikeda K, Suzuki T, Tate G, et al. Cytomorphologic features of well-differentiated papillary mesothelioma in peritoneal effusion: a case report. Diagn Cytopathol. 2008;36:512–515
  12. King JE, Thatcher N, Pickering CA, et al. Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published date. Histopathology. 2006;48:223–232
  13. Kato Y, Tsuta K, Seki K, et al. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol. 2007;20:215–220
  14. Ligato S, Zhao H, Mandich D, et al. KOC (K homology domain containing protein overexpressed in cancer) and S100A4-protein immunoreactivity improves the diagnostic sensitivity of biliary brushing cytology for diagnosing pancreaticobiliary malignancies. Diagn Cytopathol. 2008;36:561–567
  15. Xu H, Bourne PA, Spaulding BO, et al. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. Hum Pathol. 2007;38:555–563
  16. Simon R, Bourne PA, Yang Q, et al. Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not. Hum Pathol. 2007;38:1178–1183
  17. Mueller-Pillasch F, Pohl B, Wilda M, et al. Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev. 1999;88:95–99

PII: S0046-8177(09)00399-2

doi: 10.1016/j.humpath.2009.04.030

Human Pathology
Volume 41, Issue 5 , Pages 745-750 , May 2010

Article Tools

* Image Usage & Resolution